Report error Found 177 Enz. Inhib. hit(s) with all data for entry = 13562
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 400nMAssay Description:Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi...More data for this Ligand-Target Pair

















































